Developments
 

Developments

In this NJR 20th anniversary year our patient representatives, the clinical leadership and NJR management team, together with the Lot 1 and Lot 2 contractors, have been reflecting on the value that the NJR dataset has brought to joint replacement healthcare, both in the UK and beyond. 

We have summarised these benefits in a series of articles being published in the Journal of Trauma and Orthopaedics (JTO) over the anniversary year (with the first of these having been published in June 2023). These articles cover the benefits the NJR provides for our stakeholder groups: patients, hospitals, surgeons, industry, service commissioners, regulators, policy-makers, and broader society, and are also addressed and summarised on the NJR website.